Shares surged 13.2% to $15.50 in after-hours trading on August 11 after Velo3D crushed Wall Street expectations, posting second-quarter revenue of $20.7 million — a 52.3% year-over-year increase that far exceeded the consensus analyst estimate of $13.52 million . For a company that nearly collapsed in 2024, the question now is whether accelerating growth can translate into actual profits before the cash runs out.
A Revenue Beat This Big Changes the Math — Management raised full-year 2026 revenue guidance to $65–$75 million, up from the prior $60–$70 million range . That's meaningful: at the midpoint, the new target of $70 million represents roughly a 52% jump from 2025 full-year revenue of about $46 million. Q1 had already delivered $13.8 million in revenue , meaning Q2's $20.7 million shows genuine sequential acceleration — the company isn't just coasting on easy comparisons.
Defense Spending Is the Engine, Not Hype — Velo3D secured a $9.8 million, five-year contract with the Defense Logistics Agency earlier this year, and the broader push to reshore critical manufacturing is feeding its order book. Management credits "increasing demand for advanced metal additive manufacturing solutions" — essentially, the Pentagon and aerospace primes want American-made metal parts printed on demand rather than sourced from fragile overseas supply chains.
A Massive Factory Bet Raises the Stakes — The company just opened a 289,000-square-foot facility in Livermore, California — one of the largest metal 3D-printing buildouts in North America . It can house more than 40 large-format printing systems at launch, with room for over 100 . Tripling capacity is bold for a company that ended Q1 with just $16.6 million in cash and planned capital spending of $40–$50 million this year . More fundraising seems inevitable.
Profitability Is Still a Promise, Not a Reality — Gross margin improved by nearly 10 percentage points to 17.2% in Q1 , and management targets 30%+ in the second half. The company expects to hit positive EBITDA — essentially, earnings before interest, taxes, and accounting charges — in the second half of 2026 . But adjusted EBITDA was negative $33.3 million for all of 2025 . Analysts carry a consensus "Strong Buy" with an average price target of $23.75 , suggesting further upside — if management delivers. The turnaround story is real, but so is the dilution risk.